Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AEMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 6.235M
March 31, 2026 6.333M
December 31, 2025 8.057M
September 30, 2025 7.323M
June 30, 2025 5.306M
March 31, 2025 7.360M
December 31, 2024 6.525M
September 30, 2024 8.847M
June 30, 2024 11.42M
March 31, 2024 8.246M
December 31, 2023 10.44M
September 30, 2023 12.83M
June 30, 2023 15.80M
March 31, 2023 17.51M
December 31, 2022 20.72M
September 30, 2022 23.05M
June 30, 2022 17.13M
March 31, 2022 19.42M
December 31, 2021 21.92M
September 30, 2021 23.87M
June 30, 2021 25.87M
March 31, 2021 10.67M
December 31, 2020 12.67M
September 30, 2020 15.06M
June 30, 2020 16.43M
Date Value
March 31, 2020 10.39M
December 31, 2019 4.682M
September 30, 2019 1.282M
June 30, 2019 2.933M
March 31, 2019 4.123M
December 31, 2018 4.951M
September 30, 2018 5.272M
June 30, 2018 6.454M
March 31, 2018 7.352M
December 31, 2017 5.751M
September 30, 2017 1.146M
June 30, 2017 0.5092M
March 31, 2017 1.726M
December 31, 2016 0.7896M
September 30, 2016 0.9508M
June 30, 2016 1.461M
March 31, 2016 2.557M
December 31, 2015 3.593M
September 30, 2015 4.706M
June 30, 2015 5.974M
March 31, 2015 1.381M
December 31, 2014 3.156M
September 30, 2014 1.089M
June 30, 2014 1.144M
March 31, 2014 1.695M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M
Baxter International, Inc. 19.79B

Total Assets (Quarterly) Related Metrics